Company Filing History:
Years Active: 2006
Title: Gottfried Heinisch: Innovator in Anti-Cancer Therapeutics
Introduction
Gottfried Heinisch is a notable inventor based in Innsbruck, Austria. He has made significant contributions to the field of medicinal chemistry, particularly in the development of anti-cancer agents. His innovative work has the potential to impact cancer treatment significantly.
Latest Patents
Heinisch holds a patent for "Heterocyclic hydrazones for use as anti-cancer agents." This invention relates to novel 2-benzimidazolyl-, 2-benzoxazolyl-, and 2-benzothiazolyl hydrazones derived from various chemical compounds. The patent outlines a novel method for producing these hydrazones and highlights their effectiveness as therapeutic agents against cancer, including multidrug-resistant cancer cells. He has 1 patent to his name.
Career Highlights
Gottfried Heinisch is associated with Austria Wirtschaftsservice Gesellschaft mit beschränkter Haftung, where he continues to advance his research and development efforts. His work is characterized by a commitment to finding innovative solutions to complex medical challenges.
Collaborations
Heinisch has collaborated with notable colleagues in his field, including Johann Hofmann and Johnny Easmon. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.
Conclusion
Gottfried Heinisch is a prominent figure in the realm of anti-cancer research, with a focus on developing effective therapeutic agents. His contributions are paving the way for advancements in cancer treatment, showcasing the importance of innovation in medicine.